Newlimit, Cofounded By Coinbase Ceo Brian Armstrong, Raises $40M To Extend Life

May 16, 2023•over 2 years ago

Amount Raised

$40 Million

South San FranciscoBiotechnology

Investors

Founders FundKleiner PerkinsDimension

Description

NewLimit, a 1.5-year-old, San Francisco-based, 17-person company that aims to increase the number of healthy years each person lives by epigenetically reprogramming cells, is today announcing that it has raised $40 million in Series A funding from Dimension, Kleiner Perkins, Founders Fund, and other investors to further its mission to extend humans’ health and lives.

Company Information

Company

NewLimit

Location

South San Francisco, California, United States

About

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends